{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:12:33Z","timestamp":1778577153329,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HO 5220\/2-1"],"award-info":[{"award-number":["HO 5220\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["C06"],"award-info":[{"award-number":["C06"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["656"],"award-info":[{"award-number":["656"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004869","name":"Westf\u00e4lische Wilhelms-Universit\u00e4t M\u00fcnster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006441","name":"Center for Outcomes Research and Evaluation, Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008675","name":"Centre for Interdisciplinary Research in Rehabilitation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008675","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bmc.2019.03.056","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T03:04:02Z","timestamp":1553915042000},"page":"1997-2018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proline-based hydroxamates targeting the zinc-dependent deacetylase LpxC: Synthesis, antibacterial properties, and docking studies"],"prefix":"10.1016","volume":"27","author":[{"given":"Dmitrii V.","family":"Kalinin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriana","family":"Agoglitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Van de Vyver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Melesina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Riemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sch\u00e4fers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Sippl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Holl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bmc.2019.03.056_b0005","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1039\/b617121b","article-title":"Zinc metalloproteins as medicinal targets","volume":"37","author":"Anzellotti","year":"2008","journal-title":"Chem Soc Rev"},{"issue":"5S Suppl","key":"10.1016\/j.bmc.2019.03.056_b0010","doi-asserted-by":"crossref","first-page":"1437S","DOI":"10.1093\/jn\/130.5.1437S","article-title":"Function and mechanism of zinc metalloenzymes","volume":"130","author":"McCall","year":"2000","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.bmc.2019.03.056_b0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/pr050361j","article-title":"Counting the zinc-proteins encoded in the human genome","volume":"5","author":"Andreini","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.bmc.2019.03.056_b0020","series-title":"Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications","author":"Supuran","year":"2009"},{"issue":"8","key":"10.1016\/j.bmc.2019.03.056_b0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/nu4080875","article-title":"Cellular mechanisms of zinc dysregulation: a perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer","volume":"4","author":"Alam","year":"2012","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bmc.2019.03.056_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-3639.2006.tb00556.x","article-title":"Metallothioneins and zinc dysregulation contribute to neurodevelopmental damage in a model of perinatal viral infection","volume":"16","author":"Williams","year":"2006","journal-title":"Brain Pathol"},{"issue":"5788","key":"10.1016\/j.bmc.2019.03.056_b0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/288280a0","article-title":"A new class of angiotensin-converting enzyme inhibitors","volume":"288","author":"Patchett","year":"1980","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.bmc.2019.03.056_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00438-6","article-title":"Acetazolamide: future perspective in topical glaucoma therapeutics","volume":"248","author":"Kaur","year":"2002","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1016\/j.bmc.2019.03.056_b0045","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.bmc.2019.03.056_b0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/07853890.2016.1197416","article-title":"Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?","volume":"48","author":"Pivovarova","year":"2016","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.bmc.2019.03.056_b0055","first-page":"31","article-title":"Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine","volume":"2016","author":"Mohan","year":"2016","journal-title":"Metalloproteinases Med"},{"issue":"4","key":"10.1016\/j.bmc.2019.03.056_b0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/med.10007","article-title":"Bacterial protease inhibitors","volume":"22","author":"Supuran","year":"2002","journal-title":"Med Res Rev"},{"issue":"6","key":"10.1016\/j.bmc.2019.03.056_b0065","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1128\/AAC.00140-06","article-title":"Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa","volume":"50","author":"Mdluli","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.bmc.2019.03.056_b0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/138920108783497668","article-title":"Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis","volume":"9","author":"Barb","year":"2008","journal-title":"Curr Pharm Biotechnol"},{"issue":"21","key":"10.1016\/j.bmc.2019.03.056_b0075","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.2174\/1568026616666160413135835","article-title":"Insights into the zinc-dependent deacetylase LpxC: biochemical properties and inhibitor design","volume":"16","author":"Kalinin","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2019.03.056_b0080","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1194\/jlr.R800060-JLR200","article-title":"Discovery of new biosynthetic pathways: the lipid A story","volume":"50","author":"Raetz","year":"2009","journal-title":"J Lipid Res"},{"issue":"42","key":"10.1016\/j.bmc.2019.03.056_b0085","doi-asserted-by":"crossref","first-page":"25898","DOI":"10.1074\/jbc.271.42.25898","article-title":"Regulation of UDP-3-0-[R-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase in Escherichia coli \u2013 the second enzymatic step of lipid a biosynthesis","volume":"271","author":"Sorensen","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2019.03.056_b0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.bi.59.070190.001021","article-title":"Biochemistry of endotoxins","volume":"59","author":"Raetz","year":"1990","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.bmc.2019.03.056_b0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chembiol.2010.11.011","article-title":"Species-specific and inhibitor-dependent conformations of LpxC: implications for antibiotic design","volume":"18","author":"Lee","year":"2011","journal-title":"Chem Biol"},{"issue":"14","key":"10.1016\/j.bmc.2019.03.056_b0100","doi-asserted-by":"crossref","first-page":"8146","DOI":"10.1073\/pnas.1432990100","article-title":"Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis","volume":"100","author":"Whittington","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.bmc.2019.03.056_b0105","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1021\/bi047820z","article-title":"Refined solution structure of the LpxC-TU-514 complex and pKa analysis of an active site histidine: insights into the mechanism and inhibitor design","volume":"44","author":"Coggins","year":"2005","journal-title":"Biochemistry"},{"issue":"47","key":"10.1016\/j.bmc.2019.03.056_b0110","doi-asserted-by":"crossref","first-page":"34073","DOI":"10.1074\/jbc.M113.513028","article-title":"Structure of the bacterial deacetylase LpxC bound to the nucleotide reaction product reveals mechanisms of oxyanion stabilization and proton transfer","volume":"288","author":"Clayton","year":"2013","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bmc.2019.03.056_b0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.abb.2004.08.006","article-title":"Zinc hydrolases: the mechanisms of zinc-dependent deacetylases","volume":"433","author":"Hernick","year":"2005","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"10.1016\/j.bmc.2019.03.056_b0120","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1021\/jp075415m","article-title":"DFT investigation on the mechanism of the deacetylation reaction catalyzed by LpxC","volume":"112","author":"Robinet","year":"2008","journal-title":"J Phys Chem B"},{"issue":"17","key":"10.1016\/j.bmc.2019.03.056_b0125","doi-asserted-by":"crossref","first-page":"16969","DOI":"10.1074\/jbc.M413560200","article-title":"UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase functions through a general acid-base catalyst pair mechanism","volume":"280","author":"Hernick","year":"2005","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.bmc.2019.03.056_b0130","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/bi902066t","article-title":"Activation of Escherichia coli UDP-3-O-[(R)-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase by Fe2+ yields a more efficient enzyme with altered ligand affinity","volume":"49","author":"Hernick","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2019.03.056_b0135","first-page":"1","article-title":"LpxC inhibitors: a patent review (2010\u20132016)","author":"Kalinin","year":"2017","journal-title":"Expert Opin Ther Pat"},{"issue":"50","key":"10.1016\/j.bmc.2019.03.056_b0140","doi-asserted-by":"crossref","first-page":"16574","DOI":"10.1021\/bi0518186","article-title":"A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin","volume":"44","author":"McClerren","year":"2005","journal-title":"Biochemistry"},{"issue":"36","key":"10.1016\/j.bmc.2019.03.056_b0145","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1039\/c3ob41082j","article-title":"Synthesis and biological evaluation of flexible and conformationally constrained LpxC inhibitors","volume":"11","author":"L\u00f6ppenberg","year":"2013","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2019.03.056_b0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2016.01.032","article-title":"Chiral pool synthesis and biological evaluation of C-furanosidic and acyclic LpxC inhibitors","volume":"110","author":"M\u00fcller","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2019.03.056_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.carres.2012.06.006","article-title":"Design and stereoselective synthesis of a C-aryl furanoside as a conformationally constrained CHIR-090 analogue","volume":"359","author":"Oddo","year":"2012","journal-title":"Carbohydr Res"},{"issue":"47","key":"10.1016\/j.bmc.2019.03.056_b0160","doi-asserted-by":"crossref","first-page":"18433","DOI":"10.1073\/pnas.0709412104","article-title":"Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: time-dependent inhibition and specificity in ligand binding","volume":"104","author":"Barb","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1016\/j.bmc.2019.03.056_b0165","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1021\/acs.jmedchem.6b01291","article-title":"novel potent proline-based metalloproteinase inhibitors: design, (radio)synthesis, and first in Vivo evaluation as radiotracers for positron emission tomography","volume":"59","author":"Kalinin","year":"2016","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2019.03.056_b0170","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.bmc.2013.12.057","article-title":"Synthesis, biological evaluation and molecular docking studies of benzyloxyacetohydroxamic acids as LpxC inhibitors","volume":"22","author":"Szermerski","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2019.03.056_b0175","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.carres.2012.08.023","article-title":"Stereocontrolled synthesis of four diastereomeric C-aryl manno- and talofuranosides","volume":"361","author":"Ravarino","year":"2012","journal-title":"Carbohydr Res"},{"issue":"9","key":"10.1016\/j.bmc.2019.03.056_b0180","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/S0040-4020(01)81717-8","article-title":"Synthesis from D-Mannose of 1,4-Dideoxy-1,4-Imino-L-Ribitol and of the Alpha-Mannosidase Inhibitor 1,4-Dideoxy-1,4-Imino-D-Talitol","volume":"44","author":"Fleet","year":"1988","journal-title":"Tetrahedron"},{"issue":"9","key":"10.1016\/j.bmc.2019.03.056_b0185","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/S0040-4020(01)81716-6","volume":"44","author":"Fleet","year":"1988","journal-title":"Tetrahedron"},{"issue":"24","key":"10.1016\/j.bmc.2019.03.056_b0190","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1016\/j.bmc.2011.07.053","article-title":"Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols","volume":"19","author":"Bello","year":"2011","journal-title":"Bioorgan Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2019.03.056_b0195","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.bmc.2019.03.056_b0200","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1021\/ja3109664","article-title":"Proline editing: a general and practical approach to the synthesis of functionally and structurally diverse peptides. Analysis of steric versus stereoelectronic effects of 4-substituted prolines on conformation within peptides","volume":"135","author":"Pandey","year":"2013","journal-title":"J Am Chem Soc"},{"issue":"12","key":"10.1016\/j.bmc.2019.03.056_b0205","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1039\/C5SC02211H","article-title":"Importance of dipole moments and ambient polarity for the conformation of Xaa-Pro moieties - a combined experimental and theoretical study","volume":"6","author":"Siebler","year":"2015","journal-title":"Chem Sci"},{"issue":"1","key":"10.1016\/j.bmc.2019.03.056_b0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U","article-title":"The hydrogen bond in the solid state","volume":"41","author":"Steiner","year":"2002","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmc.2019.03.056_b0215","series-title":"The weak hydrogen bond: in structural chemistry and biology","author":"Desiraju","year":"2001"},{"issue":"35","key":"10.1016\/j.bmc.2019.03.056_b0220","doi-asserted-by":"crossref","first-page":"22086","DOI":"10.1074\/jbc.272.35.22086","article-title":"Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases","volume":"272","author":"Huang","year":"1997","journal-title":"J Biol Chem"},{"issue":"16","key":"10.1016\/j.bmc.2019.03.056_b0225","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/jm960871c","article-title":"Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits","volume":"40","author":"MacPherson","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2019.03.056_b0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.1999.tb07683.x","article-title":"Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury","volume":"878","author":"Prescott","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.bmc.2019.03.056_b0235","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/jb.97.3.1334-1342.1969","article-title":"Mutant of Escherichia coli with anomalous cell division and ability to decrease episomally and chromosomally mediated resistance to ampicillin and several other antibiotics","volume":"97","author":"Normark","year":"1969","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.bmc.2019.03.056_b0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/jb.62.3.293-300.1951","article-title":"Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli","volume":"62","author":"Bertani","year":"1951","journal-title":"J Bacteriol"},{"issue":"15","key":"10.1016\/j.bmc.2019.03.056_b0245","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1074\/jbc.275.15.11002","article-title":"Antibacterial agents that target lipid A biosynthesis in gram-negative bacteria. Inhibition of diverse UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylases by substrate analogs containing zinc binding motifs","volume":"275","author":"Jackman","year":"2000","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bmc.2019.03.056_b0250","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/AAC.46.6.1793-1799.2002","article-title":"Antibacterial activities and characterization of novel inhibitors of LpxC","volume":"46","author":"Clements","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.bmc.2019.03.056_b0255","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/ac60302a020","article-title":"Fluorescence reaction for amino acids","volume":"43","author":"Roth","year":"1971","journal-title":"Anal Chem"},{"issue":"17","key":"10.1016\/j.bmc.2019.03.056_b0260","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1021\/jm4006753","article-title":"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (Radio)synthesis, in Vitro and first in Vivo evaluation","volume":"56","author":"Hugenberg","year":"2013","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2019.03.056_b0265","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucl. Acids Res"},{"key":"10.1016\/j.bmc.2019.03.056_b0270","unstructured":"Molecular Operating Environment (MOE), 2014.09; Chemical Computing Group Inc., 1010 Sherbrooke St. West, Suite N910, Montreal, QC, Canada, H3A 2R7, 2016."},{"issue":"5\u20136","key":"10.1016\/j.bmc.2019.03.056_b0275","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field.1. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J Comput Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619302354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619302354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:27:15Z","timestamp":1778574435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619302354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0968089619302354"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.03.056","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proline-based hydroxamates targeting the zinc-dependent deacetylase LpxC: Synthesis, antibacterial properties, and docking studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}